OpenURL Connection Search

Select item for more details and to access through your institution.

Coumarin‐Based Aldo‐Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.
Published in:
ChemMedChem, 2024, v. 19, n. 21, p. 1, doi. 10.1002/cmdc.202400081
By:
- Jonnalagadda, Sravan K.;
- Duan, Ling;
- Dow, Louise F.;
- Boligala, Geetha P;
- Kosmacek, Elizabeth;
- McCoy, Kristyn;
- Oberley‐Deegan, Rebecca;
- Chhonker, Yashpal Singh;
- Murry, Darryl J.;
- Reynolds, C. Patrick;
- Maurer, Barry J.;
- Penning, Trevor M.;
- Trippier, Paul C.
Publication type:
Article
C22:0- and C24:0-dihydroceramides Confer Mixed Cytotoxicity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.
Published in:
PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074768
By:
- Holliday Jr., Michael W.;
- Cox, Stephen B.;
- Kang, Min H.;
- Maurer, Barry J.
Publication type:
Article
Novel submicroscopic extrachromosomal elements containing amplified genes in human cells.
Published in:
Nature, 1987, v. 327, n. 6121, p. 434, doi. 10.1038/327434a0
By:
- Maurer, Barry J.;
- Lai, Eric;
- Hamkalo, Barbara A.;
- Hood, Leroy;
- Attardi, Giuseppe
Publication type:
Article
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Published in:
2000
By:
- Maurer, Barry J.;
- Melton, Lisa;
- Billups, Carolyn;
- Cabot, Myles C.;
- Reynolds, C. Patrick;
- Maurer, B J;
- Melton, L;
- Billups, C;
- Cabot, M C;
- Reynolds, C P
Publication type:
journal article
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Published in:
1999
By:
- Maurer, Barry J.;
- Metelitsa, Leonid S.;
- Seeger, Robert C.;
- Cabot, Myles C.;
- Reynolds, C. Patrick;
- Maurer, B J;
- Metelitsa, L S;
- Seeger, R C;
- Cabot, M C;
- Reynolds, C P
Publication type:
journal article
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
Published in:
2014
By:
- Kang, Min H.;
- Villablanca, Judith G.;
- Glade Bender, Julia L.;
- Matthay, Katherine K.;
- Groshen, Susan;
- Sposto, Richard;
- Czarnecki, Scarlett;
- Ames, Matthew M.;
- Patrick Reynolds, C.;
- Marachelian, Araz;
- Maurer, Barry J.
Publication type:
Case Study
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 97, doi. 10.1007/s00280-023-04543-6
By:
- Boulter, Alexis C.;
- Maurer, Barry J.;
- Pogue, Meredith;
- Kang, Min H.;
- Cho, Hwangeui;
- Knight, Amanda;
- Reynolds, C. Patrick;
- Quick, Donald;
- Awasthi, Sanjay;
- Gerber, David E.
Publication type:
Article
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 4, p. 525, doi. 10.1007/s00280-020-04224-8
By:
- Thomas, Jacob S.;
- El-Khoueiry, Anthony B.;
- Maurer, Barry J.;
- Groshen, Susan;
- Pinski, Jacek K.;
- Cobos, Everardo;
- Gandara, David R.;
- Lenz, Heinz J.;
- Kang, Min H.;
- Reynolds, C. Patrick;
- Newman, Edward M.
Publication type:
Article
P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Published in:
International Journal of Cancer, 2017, v. 141, n. 2, p. 405, doi. 10.1002/ijc.30706
By:
- Lopez‐Barcons, Lluis;
- Maurer, Barry J.;
- Kang, Min H.;
- Reynolds, C. Patrick
Publication type:
Article
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure.
Published in:
2011
By:
- Cooper, Jason P;
- Hwang, Kyunghwa;
- Singh, Hardeep;
- Wang, Dong;
- Reynolds, C Patrick;
- Curley Jr, Robert W;
- Williams, Simon C;
- Maurer, Barry J;
- Kang, Min H;
- Curley, Robert W Jr
Publication type:
journal article
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.
Published in:
Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1801, doi. 10.1002/pbc.24643
By:
- Maurer, Barry J.;
- Kang, Min H.;
- Villablanca, Judith G.;
- Janeba, Jitka;
- Groshen, Susan;
- Matthay, Katherine K.;
- Sondel, Paul M.;
- Maris, John M.;
- Jackson, Hollie A.;
- Goodarzian, Fariba;
- Shimada, Hiroyuki;
- Czarnecki, Scarlett;
- Hasenauer, Beth;
- Reynolds, C. Patrick;
- Marachelian, Araz
Publication type:
Article
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): Review from an international consensus conference.
Published in:
Pediatric Blood & Cancer, 2010, v. 54, n. 7, p. 872, doi. 10.1002/pbc.22414
By:
- Horton, Terzah M.;
- Sposto, Richard;
- Brown, Patrick;
- Reynolds, C. Patrick;
- Hunger, Stephen P.;
- Winick, Naomi J.;
- Raetz, Elizabeth A.;
- Carroll, William L.;
- Arceci, Robert J.;
- Borowitz, Michael J.;
- Gaynon, Paul S.;
- Gore, Lia;
- Jeha, Sima;
- Maurer, Barry J.;
- Siegel, Stuart E.;
- Biondi, Andrea;
- Kearns, Pamela R.;
- Narendran, Aru;
- Silverman, Lewis B.;
- Smith, Malcolm A.
Publication type:
Article

Found: 12